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ABSTRACT
Objective: Intention of the present study is to investigate the protective role of zinc against ammonium sulfate (AS) toxicity in renal tissue by evaluating 
certain biochemical activities of albino rats.
Methods: Rats were divided into four groups, namely control, ammonia, zinc, and ammonia + zinc. Rats were exposed to AS (18.3 mg/kg body weight) 
or zinc chloride (4 mg/kg body weight) or both through intraperitoneally for 7-day experimentation with 24-h time interval.
Results: Increased levels of ammonia, urea, glutamine, glutamine synthetase, free amino acids, lactate dehydrogenase, and decreased levels of total 
proteins, pyruvate, succinate dehydrogenases and malate dehydrogenase have been observed in AS-treated rats when compared with the control 
group. Supplementation of zinc mitigated AS-induced oxidative stress and restored all the biochemical parameter activities. Zinc administered to 
normal rats did not exhibit any significant changes in any of the parameters studied.
Conclusion: According to this study, one can conclude that the zinc supplementation has effectively recovered the mitochondrial enzyme activities 
and ammonia metabolic biochemical parameters in renal tissue of the AS-treated rats.
Keywords: Ammonium sulfate, Zinc chloride, Renal tissue, Oxidative enzymes, Hyperammonemia.
INTRODUCTION
Ammonium sulfate (AS) is one of the inorganic popular fertilizers in 
the agriculture field used for the increasing of crop yield. Ammonium 
compounds are also used in food and beverage industries and printing 
industries. Utilization in excess of nitrogenous pollutants actually 
enters the aquatic ecosystem and runoff from land and industrial 
sewage, results in toxic effect on living forms as well as terrestrial 
forms through the food chain, and accumulated in their body [1]. The 
excessive production of ammonium levels in the body is associated with 
the using of antiepileptic and chemotherapeutic drugs such as valproic 
acid, salicylate, L-asparaginase, infections, and structural defects [2,3]. 
Ammonium absorbed by the digestive gut is metabolized to urea in 
the liver and eliminated through renal organ [4]. Insufficient removal 
of ammonia in the liver [5] or portacaval shunting causes an increase 
of ammonia levels in the brain [6], which are responsible for the 
development of hyperammonemia. Hyperammonemia consequently 
leads to hepatic encephalopathy [7] and kidney disorder. The major 
toxic effects of ammonia likely involve changes in cellular pH and 
the depletion of certain citric acid cycle intermediates, in particular, 
alpha-ketoglutarate [8]. Several studies also revealed the impact of 
ammonium-related compounds (chloride, acetate, nitrate, and sulfate) 
on renal functions [9-12]. In spite of extensive investigations, the precise 
was to investigate the anti-hyperammonemia drugs for therapeutic role 
against the ammonia-induced stress which are not reported.
In the present study, zinc selected as a therapeutic drug against the 
ammonia stress. Zinc is a well-known multipurpose ubiquitous trace 
element and required for indispensable growth and development 
of microorganisms, plants, and animals. A sufficient intake of zinc 
is important for as it supports the body to regulate the key functions 
including cell proliferation, immune functions, protein synthesis, cell 
division, carbohydrate metabolism, DNA synthesis, and reproductive 
functions [13-15]. Zinc protects the cell from oxidative stress through 
scavenging of reactive oxygen species (ROS) by the generation of free 
radicals in metabolic acidosis in diseased conditions [16]. Previous 
studies also revealed the zinc protective role on kidney necrosis against 
the cadmium, cisplatin, gentamicin, and lead toxicity [17-20]. Zinc 
supplementation inhibits the acute kidney disorders in hemodialysis 
patients [21]. The increased levels of urea and creatinine levels are 
reduced by zinc supplementation in liver cirrhosis patients [22]. The 
unique properties of zinc may have significant therapeutic benefits in 
several diseases in humans. Although many in vivo and clinical trials 
have been conducted using these dietary supplementations, their 
biochemical and chemical mechanisms of efficacy are the focus of much 
current research.
Therefore, the intention of the present study is to investigate the 
influence of zinc on activity levels of ammonia, urea, glutamine, 
glutamine synthetase, total proteins, free amino acids, pyruvate, and 
oxidative enzymes such as malate dehydrogenase (MDH), lactate 
dehydrogenase (LDH), and succinate dehydrogenase (SDH) in animal 
model of AS-induced stress conditions.
METHODS
Experimental animals
Male Wistar strain rats were purchased from the certified dealer 
(Raghavendra Enterprises, Bangalore, India) and used in the present 
study as an experimental model. Rats were housed in polypropylene 
cages lined with sterilized paddy husk as bed linen material and 
renewed every 24 h with ad libitum access to tap water and rat chew 
(purchased from Sai Durga Agencies, Bangalore, India). The animals 
maintained in well a controlled environment (25±2°C) with a 12-h light 
and 12-h dark cycle. The experiments were carried out in accordance 
with the guidelines of the Institutional Animal Ethical Committee, 
Sri Venkateswara University, Tirupati, India (Resolution Number: 
06/2012-2013/(I)/(a) CPCSEA/IAEC/SVU/PN-ASR/dt. 01.02.2012).
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Experimental design
The total of 24 healthy adult Wistar rats was used for the present 
study and they were divided into four groups containing six animals 
in each: Group I: Served as control, Group II: animals treated with AS 
(18.3 mg/kg bw; i. p), Group III: animals treated with zinc chloride 
(ZnCl2) (4 mg/kg bw; i. p) for comparing with the control group, 
and Group IV: animals treated with AS along with ZnCl2, for 7 days 
within 24 h time interval. The control and experimental animals 
at the end of the 7th day were fasted overnight and sacrificed by 
cervical dislocation. Kidney tissues excised immediately, rinsed in ice-
chilled normal saline, kept in a deep freezer at −20°C, and used for 
biochemical analysis.
Biochemical analysis
Ammonia and urea levels in kidney tissue were estimated by the 
methods of Bergmeyer [23] and Natelson [24]. Glutamine was 
estimated by the acid hydrolysis method as described by Colowick and 
Kalpan [25]. The activity of glutamine synthetase was estimated by the 
method of Chung [26]. The total protein, total free amino acids, and 
pyruvic acid levels were estimated by the method of Lowry et al. [27], 
Moore and Stein [28], and Friedman and Hangen, respectively [29].
Assay of the oxidative metabolic enzymes
Lactate dehydrogenase
LDH was assayed by measuring the formation of NAD from NADPH 
during the reduction of pyruvate according to the method of Nachlas 
et al. [30] as slightly modified by Prameelamma et al. [31]. The weighed 
renal tissue homogenate (10%) in ice-cold 0.25-m sucrose solution and 
centrifuged at 1000 g for 15 min at 4°C. Carefully collected supernatant 
was used for the enzyme assay. Reaction mixture final volume (2 ml) 
contained 40 µmoles of sodium lactate, 100 µmoles of phosphate buffer 
(pH 7.0), 0.1 µmole of NAD, and 4 µmole of iodonitrotetrazolium (INT). 
Reaction mixture incubated for 30 min at 37°C and 5 ml of glacial acetic 
acid added to this for Stoppard of reaction. The formazan extracted 
overnight in 5 ml of toluene at 5°C; developed color measured at 
495 nm in spectrophotometer against the toluene blank.
Succinate dehydrogenase
The activity of SDH assayed in the liver of rats by the method of 
Nachlas et al., [30] as modified by Prameelamma et al. [31]. The tissue 
was homogenized (10% w/v) in 0.25 M ice-cold sucrose solution. 
The homogenate centrifuged at 5000 revolutions per minute (RPM) 
for 30 min to remove cell debris and nuclei. The supernatant passed 
through cheesecloth and centrifuged at 16,000 RPM for 60 min to 
obtain the mitochondrial pellet. The washed pellet dispersed in 
0.25 M ice-cold sucrose solution and used as enzyme source. Isolation 
of mitochondria carried out at 4°C. The reaction mixture in a final 
volume of 2.0 ml contained 40 μM of sodium succinate, 100 μM of 
sodium phosphate buffer, pH 7.4, and 4 μM of 3-(4-iodophenyl) 
3-(4-nitrophenyl)-5-phenyl tetrazolium chloride (INT). The reaction 
initiated by the addition of appropriate amount of enzyme protein. The 
incubation carried out for 30 min at 37°C in a thermostated water bath 
and the reaction arrested by the addition of 5 ml glacial acetic acid. 
The formazan formed extracted overnight in 5 ml of toluene at 4°C. 
The intensity of the color measured at 495 nm in spectrophotometer 
(Hitachi model U, 2001) against zero time control. The SDH activity 
expressed as μM of formazan formed/mg protein/h.
Malate dehydrogenase
MDH activity was determined by the method described by Nachlas 
et al., [30] as suggested by Prameelamma et al. [31] with slight 
modifications. 10% (w/v) homogenates of the kidney tissue were 
prepared in ice-cold 0.25 M sucrose solution and centrifuged at 1000 g 
for 15 min at 4°C. The supernatant fraction used for enzyme assay. 
The reaction mixture in a final volume of 2 ml contained 40 moles of 
sodium malate, 100 moles of phosphate buffer (PH −7.0), 0.1 moles 
of NAD, and 4 moles of INT. The reaction initiated by the addition of 
0.2 ml of homogenate containing 20 mg of tissue as an enzyme source 
and incubated for 30 min at 37°C and the reaction stopped by the 
addition of 5 ml of the glacial acetic acid. Zero time controls maintained 
by the addition of 5 ml of the glacial acetic acid before the addition of 
the enzyme source to the incubation mixture. The formazan formed 
extracted overnight into 5 ml of toluene at 5°C. The developed color 
measured at 495 nm in a spectrophotometer against the toluene blank.
Statistical analysis
Data were statistically analyzed using one-way analysis of variance 
followed by Dennett’s multiple comparison test. The values p<0.05 
were considered statistically significant. The data presented as 
mean ± standard deviation. All statistical tests performed using the 
Statistical Package for the Social Sciences (SPSS), version 16.0.
RESULTS
Ammonia, urea, glutamine, and glutamine synthetase activity levels 
of control and experimental animal results shown in Table 1. Under 
the ammonia stress, the activities of ammonia, urea, glutamine, and 
glutamine synthetase levels were significantly (p<0.05) increased when 
compared with a controlled group of animals. At the same time, zinc 
along with AS-administered group showed significant stabilized levels 
of biochemical activities compared with ammonium alone-treated 
group. Rats treated with ZnCl2 only showed no significant variation 
compared to control rats.
Fig. 1a-c represents the total proteins, free amino acids, and pyruvate 
activity levels in control and experimental groups. AS-treated group 
showed that reduced levels of total proteins, pyruvate activity levels, 
and elevated levels of free amino acid levels observed in AS-treated 
groups when compared with the control group. Zinc supplementation 
along with ammonium-administered group showed that significantly 
increased total proteins, pyruvate levels, and reduced levels of free 
amino acids as compared with ammonium-treated group. Zinc alone-
treated group showed that no significant variations when compared 
with the control group, but there is a significant difference with 
ammonium-treated group.
The mitochondrial metabolic oxidative enzymes such as SDH, MDH, 
and LDH activity levels in control and experimental groups showed 
in Table 2. SHD and MDH activity levels significantly decreased, 
whereas LDH levels significantly increased in AS-treated groups when 
compared with the control group. Zinc supplementation to ammonium-
administered group showed that significantly increased SDH and MDH 
and reduced levels of LDH as a contrast with the ammonium-treated 
group. No significant variations found in zinc alone-treated group.
DISCUSSION
Ammonia plays an important role in the body to maintain several 
metabolic functions at required levels (<40 mmol/L) [32]. However, at 
excess levels, ammonia became toxic, leads to functional disturbance in 
central nervous system that could lead to coma and death of the animal. 
Therefore, to avoid the deleterious effect of ammonia, terrestrial 
(ureotelic) animals detoxify the ammonia by incorporating into urea 
by transamination and deamination process in the liver and eliminated 
through urine by the kidneys [33]. The current therapeutic strategies 
directed toward reducing circulating concentrations of ammonia. The 
two main pathways of ammonia detoxification are the synthesis of 
urea and glutamine. In the physiological state, the liver is central in 
urea synthesis and this forms the basis of ammonia removal [34]. In 
the presence of liver disease, however, loss of functional liver mass and 
portacaval shunting may contribute to increased ammonia levels in 
plasma, thus predisposing to hepatic encephalopathy [35]. In cirrhotic 
patients, skeletal muscles play an important role in the detoxification 
of ammonia to glutamine. Glutamine synthesis is, however, only a 
temporary method of ammonia detoxification. To remove ammonia 
from the body in a situation when urea synthesis compromised (as 
happens in liver disease) requires transport of glutamine to the kidney, 
where it metabolized to release ammonia, which then excreted in 
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urine [34]. Renal nitrogen excretion consists almost completely of urea 
and ammonia. The two major components of renal nitrogen excretion, 
urea and ammonia, regulated by a wide variety of conditions and play 
important roles in normal health and disease, including roles in the 
urine concentrating mechanism and in acid-base homeostasis [36].
Kidneys are main homeostatic organs in the body, they perform the two 
essential roles; first, they eliminate the nitrogenous products from the 
body, and second, they regulate the minimum needed constituents of the 
body fluids. Urea, uric acid, ammonia, and creatine are the renal markers 
for analysis of kidney functions. Urea is a major nitrogenous end product 
of proteins and amino acid catabolism. In the kidneys, urea filtered out 
of the blood by the glomerular and partially reabsorbed with water. 
Creation is a catabolic product of the creatine phosphate in muscle and 
usually eliminated by the kidneys. If any alterations in the renal markers, 
it will lead to structural and functional changes in the kidneys.
Table 1: Effect of zinc on certain biochemical changes of ammonia, urea, glutamine, and glutamine synthetase levels in control and 
experimental rats renal tissue
Groups/parameter Ammonia (µ moles 
of ammonia/g wet 
weight of the tissue)
Urea (µ mole of 
urea/g wet weight 
of the tissue)
Glutamine (µ moles 
of glutamine/g wet 
weight of the tissue)
Glutamine synthetase (µ moles 
of glutamyl hydroxamate 
formed/mg of tissue/h)
Control 4.80±0.31 0.72±0.038 7.8±0.57 0.59±0.062
Ammonium sulfate 8.63±0.26* 0.97±0.025* 10.78±0.72* 0.82±0.095*
Zinc chloride 4.90±0.27 (NS) 0.73±0.040 (NS) 7.89±0.65 (NS) 0.61±0.048 (NS)
Ammonium sulfate+zinc chloride 6.21±0.35** 0.79±0.042** 8.92±0.59** 0.72±0.069**
All the values are mean of six individual observations. *Values are significantly over control at p<0.05, **Values are significantly over ammonium sulfate at p<0.05. 
NS: Not significant over control
Table 2: Changes of mitochondrial oxidative enzymes levels in the control and experimental rat’s renal tissue
Groups/parameter MDH (µ moles of formozone 
formed/mg protein/h)
LDH (µ moles of formozone 
formed/mg protein/h)
SDH (µ moles of formozone 
formed/mg protein/h)
Control 0.6887±0.014 1.5087±0.0153 0.5692±0.0171
Ammonium sulfate 0.498±0.0244* 2.0121±0.0261* 0.3685±0.0271*
Zinc chloride 0.6867±0.0151 (NS) 1.4877±0.0068 (NS) 0.556±0.0143 (NS)
Ammonium sulfate+zinc chloride 0.564±0.0324** 1.6441±0.0149** 0.514±0.0106**
All the values are mean of six individual observations. *Values are significantly over control at p<0.05, **Values are significantly over ammonium sulfate at p<0.05. 
NS: Not significant over control, MDH: Malate dehydrogenase, SDH: Succinate dehydrogenase, LDH: Lactate dehydrogenase
Fig. 1: (a) The total protein levels in renal tissue of albino rats exposed to ammonium sulfate and zinc chloride and effect of zinc chloride 
along with ammonium sulfate-treated rats. * -Values are significantly over control at p<0.05, NS - Values are not significant over control, 
** - Values are significantly over ammonium sulfate at p<0.05. (b) The free amino acids levels in renal tissue of albino rats exposed to 
ammonium sulfate and zinc chloride and effect of zinc chloride along with ammonium sulfate-treated rats. * - Values are significantly 
over control at p<0.05, NS - Values are not significant over control, ** - Values are significantly over ammonium sulfate at p<0.001. 
(c) The pyruvate levels in renal tissue of albino rats exposed to ammonium sulfate and zinc chloride and effect of zinc chloride along with 
ammonium sulfate-treated rats. * - Values are significantly over control at p<0.05, NS - Values are not significant over control, ** - Values 
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In the current study, ammonia and urea levels exhibited a significant 
increment in AS-treated rats. This increase in ammonia levels may be 
due to the degradation of proteins, leading to elevation of free amino 
acids in the body fluids. The excessive levels of free amino acids 
enhance the ammonia and urea production. Our results revealed that 
the concentration of urea was significantly elevated in the AS-treated 
group compared to control group. The slight and significant rise in the 
urea levels may be due to the impairment of the glomerular function 
and tubular damage to the kidneys under hyperammonia stress. The 
elevated levels of urea and ammonia (end products) in renal tissue, 
especially urea, indicate poor clearance of these substances by the 
kidneys rather than the excessive production. The hyperammonia stress 
may cause the increase in the hydrogen ion (pH) concentration in renal 
tubules, probably leading to acidosis in renal tubules and affect the 
glomerular filtration and tubular secretion because the kidneys work 
at particular pH levels [33]. The acidosis causes the renal injury, leads 
to functional alteration and impairment of elimination of end products 
properly. Thenmozhi and Subramanian reported that ammonium 
chloride treatments caused significant increase in blood ammonia 
and plasma urea in albino rats [37]. Ammonium acetate-treated rats 
also showed the increased levels of ammonia and urea levels in blood. 
The increased levels of urea and ammonia levels [8] indicate that 
hyperammonemia stress might induce oxidative stress in renal tissue 
and that lead to generation of free radicals and ROS and probably 
lead to hydrogen ion levels in renal tubules. Elevated levels of H + ion 
concentration represent the increasing the acidosis. Interestingly, our 
results indicated that coadministration of ZnCl2 to AS-treated group 
restored ammonia and urea concentrations within normal limits. 
Hence, it clearly indicates that zinc supplementation might inhibit 
the hyperammonemia stress and alteration of ammonia, urea levels 
restored to normal conditions. Previous studies also reported that zinc 
supplementation successfully prevents the alteration of renal markers 
by toxic substances. Babaknejad et al. studied the zinc and magnesium 
combined protective role against the cadmium-induced nephrotoxicity 
in rats, the elevated levels of renal markers such as urea and creatine 
levels restored successfully in zinc-administered rats [38]. Mesquita 
et al. reported that the mercury chloride-induced renal marker 
alterations have been reduced by the zinc supplementation in female 
rats. Increased levels of serum urea, creatine, and urine protein levels 
restored by zinc supplementation in gentamicin nephrotoxicity [39]. 
Another study also reported a nephroprotective role of zinc against 
gentamicin-induced renal failure in male albino rats, the elevated levels 
of serum ammonia, urea, and urinary protein levels were stabilized by 
ZnCl2 supplementation and renal morphological structure resorted to 
normal [19]. Zinc deficiency leads to renal failure as well as the reason 
behind to chronic kidney disorder. Adequate supplementation of zinc 
to the chronic kidney disorder patient improves the renal tubular 
functions by stabilizing acidosis through decreased levels of nitrogen 
excess materials (urea, ammonia, and creatine) [40].
Glutamine is quantitatively the most important donor of NH3 in the 
kidney. The NH3 cleaved from glutamine by the action of phosphate-
dependent glutaminase, which subjected to pH regulation [41]. The 
carbon skeleton of glutamate in the kidney, created by the action of 
glutaminase, is converted through the formation of 2-oxoglutarate, 
succinate, fumarate, malate, and oxaloacetate to phosphoenolpyruvate 
(or malate to pyruvate directly) and then participates in gluconeogenesis. 
The glucose produced by this pathway provides up to 25% of circulating 
plasma glucose in vivo [42]. Glutamine enzyme controlled the ammonia 
production. Glutaminase enzyme removes the amide nitrogen from 
glutamine by hydrolytic reaction and liberates the ammonia. The 
glutamine reaction, unlike the glutamine synthetase reaction, does 
not involve the participation of adenine nucleotides and this strongly 
favors glutamate formation [43]. The other functional pathways 
to eliminate the ammonia toxicity are formed by the production of 
glutamine through the involvement of glutamine synthetase [44] which 
catalyzes the adenosine triphosphate (ATP)-dependent synthesis of 
glutamine from glutamate and ammonia. In addition, this enzyme 
has a major role in nitrogen metabolism since the amide group of 
glutamine and nucleotides is present [45]. In the present investigation, 
increased levels of glutamine synthetase in AS-treated rats observed. 
This indicates high mobilization of glutamate for the synthesis of 
glutamine. The results of glutamine levels were also in accordance 
with their findings. Glutamine synthetase catalyzes the ATP-dependent 
condensation of glutamate with ammonia to yield glutamine [46]. ATP 
phosphorylates glutamate to form adenosine diphosphate (ADP) and 
an acyl phosphate intermediate, r-glutamyl phosphate, which reacts 
with ammonia, forming glutamine, and inorganic phosphate. ADP 
and inorganic phosphate do not dissociate until ammonia binds and 
glutamine is released [47].
In the present study, the activity levels of total proteins and pyruvate 
levels decreased, and free amino acid levels increased under AS 
treatment compared with control. AS toxicity may lead to degradation 
of proteins in kidney tissue. The depletion of the protein fraction in 
kidney tissue may be due to their degradation and possible utilization 
for metabolic purposes. An increase in free amino acid levels was 
the result of the breakdown of protein for energy and impaired 
incorporation of amino acids in protein synthesis. The toxicants might 
affect the hormonal balance, which directly or indirectly affect the 
tissue protein levels. Free amino acids considered to act as a connecting 
link between protein and carbohydrate metabolism. The liver is an 
exclusive site for the metabolism of several amino acids and the free 
amino acid content of the liver known to change during physiological 
and pathological conditions [48]. The amino acids released during 
protein degradation due to activation of proteolysis will once again 
return to the amino acid pool, and thus, the free amino acids are the 
currency through which protein metabolism operates showing the 
interdependence of both amino acids and proteins [48]. Thus, sublethal 
dose of AS gave an increment of free amino acids levels probably due 
to ammonia stress. Pyruvate is the terminate metabolite of glycolysis 
under aerobic conditions. The level of pyruvate indicates the efficiency 
of oxidative metabolism. Decreased pyruvate levels indicate its 
role as a precursor for another product in the metabolism such as 
conversion to lactate or to form amino acids, lipids, and triglycerides. 
The conversion of pyruvate to lactate under anaerobic conditions 
favor the reoxidation of NADH2 which allows glycolysis to proceed in 
the absence of oxygen by generating sufficient NAD for the reaction 
catalyzed by glyceraldehyde 3-phosphate dehydrogenase. Decrement 
in pyruvic acid levels with increment in lactate levels suggests a shift 
in cellular respiratory metabolism, toward anaerobiosis as a prelude 
toward adaptability to cope with the enhanced energy demands. 
Cyclic adenosine monophosphate activates the phosphorylase system 
during stress condition and inhibits the pyruvate levels, thus increasing 
the lactate content [49]. The elevated levels of free amino acids and 
decreased levels of proteins, and pyruvate levels were restored in 
zinc coadministered rats with AS. Hence, zinc seems to prevent the 
degradation of proteins in renal tissue and conversion of free amino 
acids to lactate and lipids by activation of Krebs cycle intermediates.
The mitochondrial oxidative enzymes such as MDH, SDH, and LDH levels 
showed in Table 2. MDH catalyzes the conversion of oxaloacetate and 
malate utilizing the NAD/NADH coenzyme system [50]. MDH is a rather 
ubiquitous enzyme, in which several isoforms have been identified, 
dithering in their subcellular localization and their specialty for the 
coenzyme NAD or NADP. The activity of MDH depends on the rates of 
the formation of oxaloacetate and phosphoenolpyruvate from malate. 
Any change in the mitochondrial structure inhibits the activity of MDH; 
the cytosolic and mitochondrial forms of MDH are key enzymes in the 
malate-aspartate shuttle [51]. The activity levels of MDH indicate the 
status of prevailing oxidative metabolism. In the present investigation, 
decreased levels of MDH in AS-treated rats observed. The decrease in 
the specific activity of MDH in kidney tissue of rats due to ammonia 
treatment suggests decreased utilization of malate. The reduced levels 
of tricarboxylic acid cycle (TCA) intermediates may also be due to the 
decrease in MDH activity during AS-treated rats. Concisely, the reduced 
MDH activity attributed to (1) low availability of substrate, (2) lesser 
conversion of succinate-fumarate-malate, and (3) the changes in the 
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structural integrity of mitochondria. A significant decrease in the 
specific activity of NADP-ICDH and due to AS treatment observed in the 
present study indicates reduced formation of malate.
LDH is a cytosolic enzyme, which allows the assessment of the process 
of anaerobic energy production by the cell [52]. This enzyme is a 
marker of metabolic activity of the renal glomerular function. Elevated 
levels of LDH represent the alteration of respiratory cycle mechanism 
because adequate levels of LDH needed for energy production by 
anaerobic process while LDH levels are increased it mostly activates the 
synthesis of lactate, accumulation of lactate leads to the formation of 
oxidative stress and disturbance of other mitochondrial enzymes (MDH 
and SDH). SDH, an enzyme of the TCA cycle, is a marker of the electron 
transport system in the inner membrane of the mitochondrion [53]. 
The changes observed in its activity due to chronic exposure to AS 
indicate disorders in the respiratory mechanisms in cells and damage 
to the mitochondrial membranes. These are located in the main 
tubules (i.e., proximal convoluted tubules and straight tubules) and 
distal convoluted tubules. Cisplatin-induced toxicity leads to elevated 
levels of LDH, urea, and creatinine phosphokinase in albino mice [54]. 
Priyadarshini and Neeraja reported that AS treatment causes the 
increment of LDH and decrement of MDH, SDH levels in liver, kidney, 
and testis tissues of male rats [55].
The current study showed that the decreased levels of MDH and SDH 
and increased levels of LDH stabilized in the zinc coadministered rats 
compared with AS-treated rats. However, the zinc-supplemented rats 
were not indicated significant variation with control rats. Therefore, 
it clearly indicates that zinc supplementation to AS improves the 
functioning of mitochondrial enzymes in the renal tissue of rat. Elevated 
LDH levels stabilized and decreased levels of MDH and SDH increased 
with zinc supplementation.
CONCLUSION
The present study demonstrated that AS is a toxic element that causes 
alteration of renal markers and biochemical parameters. AS treatment 
leads to hyperammonemia condition in rats. Zn administration with 
AS proved a protective role in experimental AS-induced acute renal 
failure. The treatment with Zn significantly diminished the alteration 
of renal function, with evidence through stabilization of renal markers 
(urea and ammonia), glutamine, and glutamine synthase levels. Zn 
supplementation also decreased free amino acid levels, LDH levels 
being significantly higher after Zn administration with AS. The 
decreased levels total proteins, pyruvate, MDH and SDH were restored 
with zinc supplementation. The obtained results showed that zinc 
supplementation prevents the hyperammonemia stress.
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